BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2449291)

  • 1. Combined effects of immunity and antitumor drugs against cancer. II. In vitro studies with cis-diamminedichloroplatinum in a human leukemia system.
    De Filippi R; Fuggetta MP; Ricci F; Marini S; Caliendo R; Giuliani A
    Chemioterapia; 1987 Dec; 6(6):410-6. PubMed ID: 2449291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of natural killer cytotoxicity by cis-diamminedichloroplatinum (II) in vivo and in vitro.
    Lichtenstein AK; Pende D
    Cancer Res; 1986 Feb; 46(2):639-44. PubMed ID: 3940633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-gamma treatment of K562 cells inhibits natural killer cell triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes.
    Grönberg A; Ferm MT; Ng J; Reynolds CW; Ortaldo JR
    J Immunol; 1988 Jun; 140(12):4397-402. PubMed ID: 3131433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of human natural cytotoxicity by Plasmodium falciparum antigen activated lymphocytes.
    Theander TG; Pedersen BK; Bygbjerg IC; Jepsen S; Larsen PB; Kharazmi A
    Acta Trop; 1987 Dec; 44(4):415-22. PubMed ID: 2449809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of recombinant interferon-alpha and 5-fluorouracil against colon cancer cells or against peripheral blood mononuclear cells.
    De Filippi R; Prete SP; Giuliani A; Silvi E; Yamaue H; Nieroda CA; Greiner JW; De Vecchis L; Bonmassar E
    Anticancer Res; 1994; 14(5A):1767-73. PubMed ID: 7847809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of biological response modifiers in immunochemotherapy of solid tumors and retroviral-induced leukemia.
    Fuggetta MP; D'Onofrio C; Bonmassar E
    Ann Ist Super Sanita; 1990; 26(3-4):385-95. PubMed ID: 1708953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of naturally occurring human spontaneous monocyte-mediated cytotoxicity by cis-diamminedichloroplatinum(II).
    Kleinerman ES; Zwelling LA; Muchmore AV
    Cancer Res; 1980 Sep; 40(9):3099-102. PubMed ID: 6448684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility to natural killer cell-mediated cytolysis is independent of the level of target cell class I HLA expression.
    Leiden JM; Karpinski BA; Gottschalk L; Kornbluth J
    J Immunol; 1989 Mar; 142(6):2140-7. PubMed ID: 2493507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor therapeutic potential of activated human umbilical cord blood cells against leukemia and breast cancer.
    Joshi SS; Tarantolo SR; Kuszynski CA; Kessinger A
    Clin Cancer Res; 2000 Nov; 6(11):4351-8. PubMed ID: 11106253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncolytic activity of NK cells against SW-756 squamous cervical carcinoma cell line: role of interferons alpha and gamma and CD54 adhesion molecule in oncolysis.
    Cristoforoni PM; Lotzová E; Cook KR; Chuang LT; Morris M; Grossi CE; Wharton JT
    Gynecol Oncol; 1994 Mar; 52(3):365-72. PubMed ID: 7512522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-apoptotic seminal vesicle protein IV inhibits cell-mediated immunity.
    Fuggetta MP; Lanzilli G; Cottarelli A; Ravagnan G; Cartenì M; De Maria S; Metafora BM; Metafora V; Metafora S
    J Reprod Immunol; 2008 Jul; 78(2):85-93. PubMed ID: 18243331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytotoxic action of natural killer cells on human tumor cells].
    Avdeev GI; Viadro MM; Leĭkin IuD; Timofeevskaia EA; Osipov SG
    Biull Eksp Biol Med; 1985 Apr; 99(4):471-3. PubMed ID: 3986372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro effect of hyperthermia on natural cell-mediated cytotoxicity.
    Fuggetta MP; Alvino E; Tricarico M; D'Atri S; Pepponi R; Prete SP; Bonmassar E
    Anticancer Res; 2000; 20(3A):1667-72. PubMed ID: 10928089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of D-glucosamine on human natural killer activity in vitro.
    Matheson DS; Green BJ; Friedman SJ
    J Biol Response Mod; 1984 Aug; 3(4):445-53. PubMed ID: 6207272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells.
    Pattengale PK; Sundstrom C; Yu AL; Levine A
    Nat Immun Cell Growth Regul; 1983-1984; 3(4):165-80. PubMed ID: 6597341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced in vitro and in vivo cytotoxicity of umbilical cord blood cells against human breast cancer following activation with IL-15 and colony stimulating factors.
    Lovgren TR; Tarantolo SR; Evans C; Kuszynski CA; Joshi SS
    In Vivo; 2002; 16(6):541-50. PubMed ID: 12494899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.